Global Lateral Flow Assays - 2025 -2033
Global Lateral Flow Assays Market: Industry Outlook
The global lateral flow assays market reached US$ 6.92 billion in 2023, with a rise of US$ 7.50 billion in 2024, and is expected to reach US$ 15.68 billion by 2033, growing at a CAGR of 8.6% during the forecast period 2025-2033.
Lateral flow assays (LFAs) are seeing increased adoption as demand grows for faster, more accessible diagnostic tools. One major driver of this growth is the increased prevalence of infectious diseases and chronic conditions. As health systems face mounting pressure to identify and manage conditions early, LFAs offer a reliable and rapid testing method that supports timely clinical decisions in both acute and routine care.
Another key factor is the growing adoption of at-home and self-testing kits. People are increasingly taking a proactive role in managing their health, and LFAs provide a convenient way to test for a range of conditions without visiting a clinic. This shift is not only improving access but also helping to reduce strain on laboratory services.
At the same time, there's growing interest in the use of LFAs in emerging and low-resource settings, where access to centralized labs may be limited. Their portability, ease of use, and minimal infrastructure requirements make them well-suited for community health programs and remote care delivery.
In addition, customization and private label manufacturing are opening new possibilities for more targeted solutions. Companies are tailoring LFAs to address specific conditions, use cases, and branding needs, allowing for greater flexibility and scalability in development and deployment. Together, these trends are reinforcing the role of LFAs as a vital tool in delivering fast, practical, and accessible diagnostics across a broad range of healthcare settings.
Dynamics: Drivers & Restraints
Driver: Increased Prevalence of Infectious Diseases and Chronic Conditions
The escalating global burden of infectious diseases and chronic health conditions is a significant driver of growth in the lateral flow assays (LFA) market. LFAs are increasingly utilized at the point of care to diagnose a wide array of infections caused by viruses (such as HIV, hepatitis, and SARS-CoV-2), bacteria (like streptococcus and E. coli), and parasites (including malaria). Their rapid, user-friendly, and cost-effective nature makes them particularly valuable in managing the growing number of health threats worldwide.
According to the World Health Organization (WHO), an estimated 254 million people were living with chronic HBV infection in 2022, with 1.2 million new infections occurring annually. The burden is particularly high in the WHO Western Pacific and African Regions, where 97 million and 65 million individuals are chronically infected, respectively. Other regions also report substantial numbers: 61 million in South-East Asia, 15 million in the Eastern Mediterranean, 11 million in Europe, and 5 million in the Americas.
The rise in infectious diseases has underscored the need for swift and accessible diagnostic solutions. LFAs have proven instrumental in providing immediate results, enabling timely interventions and reducing the spread of infections. For instance, during the COVID-19 pandemic, LFAs played a crucial role in mass testing efforts, facilitating early detection and containment measures.
Beyond infectious disease detection, LFAs are expanding into chronic disease management, environmental monitoring, and food safety applications. They are now employed in detecting cancer markers, monitoring cardiac biomarkers, and assessing environmental toxins and foodborne pathogens. As the prevalence of both infectious and chronic diseases continues to rise globally, the demand for rapid, reliable, and accessible diagnostic tools like LFAs is expected to grow, further propelling the expansion of the LFA market.
Restraint: Lower Sensitivity Compared to Lab-Based Methods
Despite their convenience and speed, one of the major challenges facing LFAs is their relatively lower sensitivity when compared to centralized, lab-based methods such as PCR or ELISA. This limitation can lead to false negatives, especially in the early stages of infection when biomarker levels are low. As a result, clinical decisions based solely on LFA results may require confirmatory testing. This sensitivity gap can restrict the broader adoption of LFAs in certain high-stakes or highly regulated clinical settings, potentially slowing market growth in those segments.
Segmentation Analysis
The global lateral flow assays market is segmented based on product, technique, application, end-user, and region.
Product:
The kits and reagents segment is estimated to have 55.3% of the lateral flow assays market share.
The kits and reagents segment is projected to maintain a dominant position in the lateral flow assays (LFA) market, primarily due to their recurring demand and integral role in diagnostic testing across various applications. These kits offer a comprehensive solution, typically containing pre-measured reagents, test strips, and buffers, which simplifies the testing process and ensures consistency and reliability. Their user-friendly design eliminates the need for specialized equipment or extensive training, making them ideal for point-of-care settings, including hospitals, clinics, and home testing environments.
The growth of this segment is further fueled by several factors. The increasing prevalence of infectious diseases and chronic conditions has heightened the demand for rapid and accessible diagnostic tools. Additionally, the rising adoption of at-home and self-testing kits reflects a shift towards more patient-centric healthcare models, where individuals seek greater control over their health management.
Technological advancements, such as the integration of nanotechnology and multiplexing capabilities, have enhanced the sensitivity and specificity of LFAs, broadening their applicability and reliability. Moreover, innovations in assay chemistry and reagent stabilization have improved the shelf-life and performance of these kits, contributing to their widespread use and sustained market growth.
Geographical Share Analysis
The North America lateral flow assays market was valued at 40.2% market share in 2024
North America is projected to maintain its leadership in the lateral flow assays (LFA) market in the coming years, driven by several key factors. The region boasts a well-established healthcare infrastructure, characterized by advanced medical facilities, a high density of diagnostic centers, and widespread adoption of point-of-care testing technologies. This robust infrastructure facilitates the efficient deployment and utilization of LFAs across various healthcare settings, including hospitals, clinics, and home care environments.
Additionally, the strong regulatory frameworks in countries like the United States, exemplified by agencies such as the FDA, ensure the safety, efficacy, and rapid approval of diagnostic tools, fostering a favorable environment for the proliferation of LFAs.
The COVID-19 pandemic significantly accelerated the adoption of LFAs, as the need for rapid, accessible, and widespread testing became paramount. In response, ongoing investments in healthcare innovation have been directed towards enhancing the capabilities of LFAs, including improvements in sensitivity, multiplexing, and integration with digital health platforms. For instance, in July 2025, VolitionRx Limited developed a lateral flow device capable of quantifying nucleosomes in whole venous blood within minutes. In a blinded study involving 25 patients from intensive care and emergency departments, the device's results strongly correlated with those of Volition's established Nu. Q nucleosome assay. This advancement enables rapid, bedside detection of immune disruptions, such as those occurring in sepsis, without the need for laboratory testing.
These advancements are further propelling the adoption of LFAs in diverse applications, ranging from infectious disease detection to chronic disease monitoring and personalized medicine.
Furthermore, the increasing prevalence of chronic and infectious diseases in the region has amplified the demand for efficient diagnostic tools. Together, these factors position North America to continue its dominance in the LFA market, with sustained growth anticipated in the foreseeable future.
Major Players
The major players in the lateral flow assays market include Getinge, STERIS, Skytron, LLC, Mizuho OSI, Merivaara Corp., Hill-Rom Holdings, Inc., Medifa, Boyd Industries, and SCHMITZ medical GmbH, among others.
The global lateral flow assays market report delivers a detailed analysis with 73 key tables, more than 76 visually impactful figures, and 195 pages of expert insights, providing a complete view of the market landscape.
The global lateral flow assays market reached US$ 6.92 billion in 2023, with a rise of US$ 7.50 billion in 2024, and is expected to reach US$ 15.68 billion by 2033, growing at a CAGR of 8.6% during the forecast period 2025-2033.
Lateral flow assays (LFAs) are seeing increased adoption as demand grows for faster, more accessible diagnostic tools. One major driver of this growth is the increased prevalence of infectious diseases and chronic conditions. As health systems face mounting pressure to identify and manage conditions early, LFAs offer a reliable and rapid testing method that supports timely clinical decisions in both acute and routine care.
Another key factor is the growing adoption of at-home and self-testing kits. People are increasingly taking a proactive role in managing their health, and LFAs provide a convenient way to test for a range of conditions without visiting a clinic. This shift is not only improving access but also helping to reduce strain on laboratory services.
At the same time, there's growing interest in the use of LFAs in emerging and low-resource settings, where access to centralized labs may be limited. Their portability, ease of use, and minimal infrastructure requirements make them well-suited for community health programs and remote care delivery.
In addition, customization and private label manufacturing are opening new possibilities for more targeted solutions. Companies are tailoring LFAs to address specific conditions, use cases, and branding needs, allowing for greater flexibility and scalability in development and deployment. Together, these trends are reinforcing the role of LFAs as a vital tool in delivering fast, practical, and accessible diagnostics across a broad range of healthcare settings.
Dynamics: Drivers & Restraints
Driver: Increased Prevalence of Infectious Diseases and Chronic Conditions
The escalating global burden of infectious diseases and chronic health conditions is a significant driver of growth in the lateral flow assays (LFA) market. LFAs are increasingly utilized at the point of care to diagnose a wide array of infections caused by viruses (such as HIV, hepatitis, and SARS-CoV-2), bacteria (like streptococcus and E. coli), and parasites (including malaria). Their rapid, user-friendly, and cost-effective nature makes them particularly valuable in managing the growing number of health threats worldwide.
According to the World Health Organization (WHO), an estimated 254 million people were living with chronic HBV infection in 2022, with 1.2 million new infections occurring annually. The burden is particularly high in the WHO Western Pacific and African Regions, where 97 million and 65 million individuals are chronically infected, respectively. Other regions also report substantial numbers: 61 million in South-East Asia, 15 million in the Eastern Mediterranean, 11 million in Europe, and 5 million in the Americas.
The rise in infectious diseases has underscored the need for swift and accessible diagnostic solutions. LFAs have proven instrumental in providing immediate results, enabling timely interventions and reducing the spread of infections. For instance, during the COVID-19 pandemic, LFAs played a crucial role in mass testing efforts, facilitating early detection and containment measures.
Beyond infectious disease detection, LFAs are expanding into chronic disease management, environmental monitoring, and food safety applications. They are now employed in detecting cancer markers, monitoring cardiac biomarkers, and assessing environmental toxins and foodborne pathogens. As the prevalence of both infectious and chronic diseases continues to rise globally, the demand for rapid, reliable, and accessible diagnostic tools like LFAs is expected to grow, further propelling the expansion of the LFA market.
Restraint: Lower Sensitivity Compared to Lab-Based Methods
Despite their convenience and speed, one of the major challenges facing LFAs is their relatively lower sensitivity when compared to centralized, lab-based methods such as PCR or ELISA. This limitation can lead to false negatives, especially in the early stages of infection when biomarker levels are low. As a result, clinical decisions based solely on LFA results may require confirmatory testing. This sensitivity gap can restrict the broader adoption of LFAs in certain high-stakes or highly regulated clinical settings, potentially slowing market growth in those segments.
Segmentation Analysis
The global lateral flow assays market is segmented based on product, technique, application, end-user, and region.
Product:
The kits and reagents segment is estimated to have 55.3% of the lateral flow assays market share.
The kits and reagents segment is projected to maintain a dominant position in the lateral flow assays (LFA) market, primarily due to their recurring demand and integral role in diagnostic testing across various applications. These kits offer a comprehensive solution, typically containing pre-measured reagents, test strips, and buffers, which simplifies the testing process and ensures consistency and reliability. Their user-friendly design eliminates the need for specialized equipment or extensive training, making them ideal for point-of-care settings, including hospitals, clinics, and home testing environments.
The growth of this segment is further fueled by several factors. The increasing prevalence of infectious diseases and chronic conditions has heightened the demand for rapid and accessible diagnostic tools. Additionally, the rising adoption of at-home and self-testing kits reflects a shift towards more patient-centric healthcare models, where individuals seek greater control over their health management.
Technological advancements, such as the integration of nanotechnology and multiplexing capabilities, have enhanced the sensitivity and specificity of LFAs, broadening their applicability and reliability. Moreover, innovations in assay chemistry and reagent stabilization have improved the shelf-life and performance of these kits, contributing to their widespread use and sustained market growth.
Geographical Share Analysis
The North America lateral flow assays market was valued at 40.2% market share in 2024
North America is projected to maintain its leadership in the lateral flow assays (LFA) market in the coming years, driven by several key factors. The region boasts a well-established healthcare infrastructure, characterized by advanced medical facilities, a high density of diagnostic centers, and widespread adoption of point-of-care testing technologies. This robust infrastructure facilitates the efficient deployment and utilization of LFAs across various healthcare settings, including hospitals, clinics, and home care environments.
Additionally, the strong regulatory frameworks in countries like the United States, exemplified by agencies such as the FDA, ensure the safety, efficacy, and rapid approval of diagnostic tools, fostering a favorable environment for the proliferation of LFAs.
The COVID-19 pandemic significantly accelerated the adoption of LFAs, as the need for rapid, accessible, and widespread testing became paramount. In response, ongoing investments in healthcare innovation have been directed towards enhancing the capabilities of LFAs, including improvements in sensitivity, multiplexing, and integration with digital health platforms. For instance, in July 2025, VolitionRx Limited developed a lateral flow device capable of quantifying nucleosomes in whole venous blood within minutes. In a blinded study involving 25 patients from intensive care and emergency departments, the device's results strongly correlated with those of Volition's established Nu. Q nucleosome assay. This advancement enables rapid, bedside detection of immune disruptions, such as those occurring in sepsis, without the need for laboratory testing.
These advancements are further propelling the adoption of LFAs in diverse applications, ranging from infectious disease detection to chronic disease monitoring and personalized medicine.
Furthermore, the increasing prevalence of chronic and infectious diseases in the region has amplified the demand for efficient diagnostic tools. Together, these factors position North America to continue its dominance in the LFA market, with sustained growth anticipated in the foreseeable future.
Major Players
The major players in the lateral flow assays market include Getinge, STERIS, Skytron, LLC, Mizuho OSI, Merivaara Corp., Hill-Rom Holdings, Inc., Medifa, Boyd Industries, and SCHMITZ medical GmbH, among others.
The global lateral flow assays market report delivers a detailed analysis with 73 key tables, more than 76 visually impactful figures, and 195 pages of expert insights, providing a complete view of the market landscape.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product
2.4. Snippet by Technique
2.5. Snippet by Application
2.6. Snippet by End-User
2.7. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Increased Prevalence of Infectious Diseases and Chronic Conditions
3.1.1.2. Growing Adoption in At-Home and Self-Testing Kits
3.1.2. Restraints
3.1.2.1. Lower Sensitivity Compared to Lab-Based Methods
3.1.2.2. Regulatory Challenges and Approval Timelines
3.1.3. Opportunity
3.1.3.1. Expansion in Emerging and Low-Resource Settings
3.1.3.2. Customization and Private Label Manufacturing
3.1.4. Impact Analysis
4. GLOBAL LATERAL FLOW ASSAYS MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest largest-selling Brand
4.1.3. Market leaders with established products & Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Force Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL LATERAL FLOW ASSAYS MARKET: BY PRODUCT
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
5.1.2. Market Attractiveness Index, By Product
5.2. Kits & Reagents*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Lateral Flow Readers
6. GLOBAL LATERAL FLOW ASSAYS MARKET: BY TECHNIQUE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
6.1.2. Market Attractiveness Index, By Technique
6.2. Sandwich Assays*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Competitive Assays
6.4. Multiplex Detection Assays
7. GLOBAL LATERAL FLOW ASSAYS MARKET: BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Drug Development & Quality Testing*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Food Safety & Environmental Safety,
7.4. Pregnancy & Fertility Testing
7.5. Cardiac Markers
7.6. Infectious Diseases Testing
7.7. Drugs of Abuse Testing
7.8. Clinical Testing
7.9. Cholesterol/Lipid Testing
7.10. Other Clinical Tests
8. GLOBAL LATERAL FLOW ASSAYS MARKET: BY END-USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Pharmaceutical and Biotechnology Companies*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hospitals and Clinics
8.4. Diagnostic Laboratories
8.5. Home Care
8.6. Others
9. GLOBAL LATERAL FLOW ASSAYS MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.7.1. U.S.
9.2.7.2. Canada
9.2.7.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.7.1. Germany
9.3.7.2. U.K.
9.3.7.3. France
9.3.7.4. Spain
9.3.7.5. Italy
9.3.7.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.7.1. Brazil
9.4.7.2. Argentina
9.4.7.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.7.1. China
9.5.7.2. India
9.5.7.3. Japan
9.5.7.4. South Korea
9.5.7.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. COMPANY PROFILES
11.1. QIAGEN*
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.2.1. Product Description
11.1.2.2. Product Key Performance Indicators (KPIs)
11.1.2.3. Historic and Forecasted Product Sales
11.1.2.4. Product Sales Volume
11.1.3. Financial Overview
11.1.3.1. Company Revenue
11.1.3.2. Geographical Revenue Shares
11.1.3.3. Revenue Forecasts
11.1.4. Key Developments
11.1.4.1. Mergers & Acquisitions
11.1.4.2. Key Product Development Activities
11.1.4.3. Regulatory Approvals, etc.
11.1.4.4. SWOT Analysis
11.2. Abbott
11.3. Merck KGaA
11.4. Thermo Fisher Scientific Inc.
11.5. Hologic Inc.
11.6. PerkinElmer
11.7. Lumos Diagnostics
11.8. BioAssay Works, LLC (LIST NOT EXHAUSTIVE)
12. ASSUMPTIONS AND RESEARCH METHODOLOGY
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product
2.4. Snippet by Technique
2.5. Snippet by Application
2.6. Snippet by End-User
2.7. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Increased Prevalence of Infectious Diseases and Chronic Conditions
3.1.1.2. Growing Adoption in At-Home and Self-Testing Kits
3.1.2. Restraints
3.1.2.1. Lower Sensitivity Compared to Lab-Based Methods
3.1.2.2. Regulatory Challenges and Approval Timelines
3.1.3. Opportunity
3.1.3.1. Expansion in Emerging and Low-Resource Settings
3.1.3.2. Customization and Private Label Manufacturing
3.1.4. Impact Analysis
4. GLOBAL LATERAL FLOW ASSAYS MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest largest-selling Brand
4.1.3. Market leaders with established products & Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Force Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL LATERAL FLOW ASSAYS MARKET: BY PRODUCT
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
5.1.2. Market Attractiveness Index, By Product
5.2. Kits & Reagents*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Lateral Flow Readers
6. GLOBAL LATERAL FLOW ASSAYS MARKET: BY TECHNIQUE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
6.1.2. Market Attractiveness Index, By Technique
6.2. Sandwich Assays*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Competitive Assays
6.4. Multiplex Detection Assays
7. GLOBAL LATERAL FLOW ASSAYS MARKET: BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Drug Development & Quality Testing*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Food Safety & Environmental Safety,
7.4. Pregnancy & Fertility Testing
7.5. Cardiac Markers
7.6. Infectious Diseases Testing
7.7. Drugs of Abuse Testing
7.8. Clinical Testing
7.9. Cholesterol/Lipid Testing
7.10. Other Clinical Tests
8. GLOBAL LATERAL FLOW ASSAYS MARKET: BY END-USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Pharmaceutical and Biotechnology Companies*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hospitals and Clinics
8.4. Diagnostic Laboratories
8.5. Home Care
8.6. Others
9. GLOBAL LATERAL FLOW ASSAYS MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.7.1. U.S.
9.2.7.2. Canada
9.2.7.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.7.1. Germany
9.3.7.2. U.K.
9.3.7.3. France
9.3.7.4. Spain
9.3.7.5. Italy
9.3.7.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.7.1. Brazil
9.4.7.2. Argentina
9.4.7.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.7.1. China
9.5.7.2. India
9.5.7.3. Japan
9.5.7.4. South Korea
9.5.7.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking
11. COMPANY PROFILES
11.1. QIAGEN*
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.2.1. Product Description
11.1.2.2. Product Key Performance Indicators (KPIs)
11.1.2.3. Historic and Forecasted Product Sales
11.1.2.4. Product Sales Volume
11.1.3. Financial Overview
11.1.3.1. Company Revenue
11.1.3.2. Geographical Revenue Shares
11.1.3.3. Revenue Forecasts
11.1.4. Key Developments
11.1.4.1. Mergers & Acquisitions
11.1.4.2. Key Product Development Activities
11.1.4.3. Regulatory Approvals, etc.
11.1.4.4. SWOT Analysis
11.2. Abbott
11.3. Merck KGaA
11.4. Thermo Fisher Scientific Inc.
11.5. Hologic Inc.
11.6. PerkinElmer
11.7. Lumos Diagnostics
11.8. BioAssay Works, LLC (LIST NOT EXHAUSTIVE)
12. ASSUMPTIONS AND RESEARCH METHODOLOGY
12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
LIST OF TABLES
Table 1 Global Lateral Flow Assays Market Value, By Product, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Lateral Flow Assays Market Value, By Technique, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Lateral Flow Assays Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Lateral Flow Assays Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Lateral Flow Assays Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Lateral Flow Assays Market Value, By Product, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Lateral Flow Assays Market Value, By Product, 2022-2033 (US$ Billion)
Table 8 Global Lateral Flow Assays Market Value, By Technique, 2025, 2029 & 2033 (US$ Billion)
Table 9 Global Lateral Flow Assays Market Value, By Technique, 2022-2033 (US$ Billion)
Table 10 Global Lateral Flow Assays Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 11 Global Lateral Flow Assays Market Value, By Application, 2022-2033 (US$ Billion)
Table 12 Global Lateral Flow Assays Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 13 Global Lateral Flow Assays Market Value, By End-User, 2022-2033 (US$ Billion)
Table 14 Global Lateral Flow Assays Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 15 Global Lateral Flow Assays Market Value, By Region, 2022-2033 (US$ Billion)
Table 16 North America Lateral Flow Assays Market Value, By Product, 2022-2033 (US$ Billion)
Table 17 North America Lateral Flow Assays Market Value, By Technique, 2022-2033 (US$ Billion)
Table 18 North America Lateral Flow Assays Market Value, By Application, 2022-2033 (US$ Billion)
Table 19 North America Lateral Flow Assays Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 North America Lateral Flow Assays Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Asia-Pacific Lateral Flow Assays Market Value, By Product, 2022-2033 (US$ Billion)
Table 22 Asia-Pacific Lateral Flow Assays Market Value, By Technique, 2022-2033 (US$ Billion)
Table 23 Asia-Pacific Lateral Flow Assays Market Value, By Application, 2022-2033 (US$ Billion)
Table 24 Asia-Pacific Lateral Flow Assays Market Value, By End-User, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Lateral Flow Assays Market Value, By Country, 2022-2033 (US$ Billion)
Table 26 Europe Lateral Flow Assays Market Value, By Product, 2022-2033 (US$ Billion)
Table 27 Europe Lateral Flow Assays Market Value, By Technique, 2022-2033 (US$ Billion)
Table 28 Europe Lateral Flow Assays Market Value, By Application, 2022-2033 (US$ Billion)
Table 29 Europe Lateral Flow Assays Market Value, By End-User, 2022-2033 (US$ Billion)
Table 30 Europe Lateral Flow Assays Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 South America Lateral Flow Assays Market Value, By Product, 2022-2033 (US$ Billion)
Table 32 South America Lateral Flow Assays Market Value, By Technique, 2022-2033 (US$ Billion)
Table 33 South America Lateral Flow Assays Market Value, By Application, 2022-2033 (US$ Billion)
Table 34 South America Lateral Flow Assays Market Value, By End-User, 2022-2033 (US$ Billion)
Table 35 South America Lateral Flow Assays Market Value, By Country, 2022-2033 (US$ Billion)
Table 36 Middle East and Africa Lateral Flow Assays Market Value, By Product, 2022-2033 (US$ Billion)
Table 37 Middle East and Africa Lateral Flow Assays Market Value, By Technique, 2022-2033 (US$ Billion)
Table 38 Middle East and Africa Lateral Flow Assays Market Value, By Application, 2022-2033 (US$ Billion)
Table 39 Middle East and Africa Lateral Flow Assays Market Value, By End-User, 2022-2033 (US$ Billion)
Table 40 Middle East and Africa Lateral Flow Assays Market Value, By Country, 2022-2033 (US$ Billion)
Table 41 QIAGEN: Overview
Table 42 QIAGEN: Product Portfolio
Table 43 QIAGEN: Key Developments
Table 44 Abbott: Overview
Table 45 Abbott: Product Portfolio
Table 46 Abbott: Key Developments
Table 47 Merck KGaA: Overview
Table 48 Merck KGaA: Product Portfolio
Table 49 Merck KGaA: Key Developments
Table 50 Thermo Fisher Scientific Inc.: Overview
Table 51 Thermo Fisher Scientific Inc.: Product Portfolio
Table 52 Thermo Fisher Scientific Inc.: Key Developments
Table 53 Hologic Inc.: Overview
Table 54 Hologic Inc.: Product Portfolio
Table 55 Hologic Inc.: Key Developments
Table 56 PerkinElmer: Overview
Table 57 PerkinElmer: Product Portfolio
Table 58 PerkinElmer: Key Developments
Table 59 Lumos Diagnostics: Overview
Table 60 Lumos Diagnostics: Product Portfolio
Table 61 Lumos Diagnostics: Key Developments
Table 62 BioAssay Works, LLC: Overview
Table 63 BioAssay Works, LLC: Product Portfolio
Table 64 BioAssay Works, LLC: Key Developments
Table 1 Global Lateral Flow Assays Market Value, By Product, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Lateral Flow Assays Market Value, By Technique, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Lateral Flow Assays Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Lateral Flow Assays Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Lateral Flow Assays Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Lateral Flow Assays Market Value, By Product, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Lateral Flow Assays Market Value, By Product, 2022-2033 (US$ Billion)
Table 8 Global Lateral Flow Assays Market Value, By Technique, 2025, 2029 & 2033 (US$ Billion)
Table 9 Global Lateral Flow Assays Market Value, By Technique, 2022-2033 (US$ Billion)
Table 10 Global Lateral Flow Assays Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 11 Global Lateral Flow Assays Market Value, By Application, 2022-2033 (US$ Billion)
Table 12 Global Lateral Flow Assays Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 13 Global Lateral Flow Assays Market Value, By End-User, 2022-2033 (US$ Billion)
Table 14 Global Lateral Flow Assays Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 15 Global Lateral Flow Assays Market Value, By Region, 2022-2033 (US$ Billion)
Table 16 North America Lateral Flow Assays Market Value, By Product, 2022-2033 (US$ Billion)
Table 17 North America Lateral Flow Assays Market Value, By Technique, 2022-2033 (US$ Billion)
Table 18 North America Lateral Flow Assays Market Value, By Application, 2022-2033 (US$ Billion)
Table 19 North America Lateral Flow Assays Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 North America Lateral Flow Assays Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Asia-Pacific Lateral Flow Assays Market Value, By Product, 2022-2033 (US$ Billion)
Table 22 Asia-Pacific Lateral Flow Assays Market Value, By Technique, 2022-2033 (US$ Billion)
Table 23 Asia-Pacific Lateral Flow Assays Market Value, By Application, 2022-2033 (US$ Billion)
Table 24 Asia-Pacific Lateral Flow Assays Market Value, By End-User, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Lateral Flow Assays Market Value, By Country, 2022-2033 (US$ Billion)
Table 26 Europe Lateral Flow Assays Market Value, By Product, 2022-2033 (US$ Billion)
Table 27 Europe Lateral Flow Assays Market Value, By Technique, 2022-2033 (US$ Billion)
Table 28 Europe Lateral Flow Assays Market Value, By Application, 2022-2033 (US$ Billion)
Table 29 Europe Lateral Flow Assays Market Value, By End-User, 2022-2033 (US$ Billion)
Table 30 Europe Lateral Flow Assays Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 South America Lateral Flow Assays Market Value, By Product, 2022-2033 (US$ Billion)
Table 32 South America Lateral Flow Assays Market Value, By Technique, 2022-2033 (US$ Billion)
Table 33 South America Lateral Flow Assays Market Value, By Application, 2022-2033 (US$ Billion)
Table 34 South America Lateral Flow Assays Market Value, By End-User, 2022-2033 (US$ Billion)
Table 35 South America Lateral Flow Assays Market Value, By Country, 2022-2033 (US$ Billion)
Table 36 Middle East and Africa Lateral Flow Assays Market Value, By Product, 2022-2033 (US$ Billion)
Table 37 Middle East and Africa Lateral Flow Assays Market Value, By Technique, 2022-2033 (US$ Billion)
Table 38 Middle East and Africa Lateral Flow Assays Market Value, By Application, 2022-2033 (US$ Billion)
Table 39 Middle East and Africa Lateral Flow Assays Market Value, By End-User, 2022-2033 (US$ Billion)
Table 40 Middle East and Africa Lateral Flow Assays Market Value, By Country, 2022-2033 (US$ Billion)
Table 41 QIAGEN: Overview
Table 42 QIAGEN: Product Portfolio
Table 43 QIAGEN: Key Developments
Table 44 Abbott: Overview
Table 45 Abbott: Product Portfolio
Table 46 Abbott: Key Developments
Table 47 Merck KGaA: Overview
Table 48 Merck KGaA: Product Portfolio
Table 49 Merck KGaA: Key Developments
Table 50 Thermo Fisher Scientific Inc.: Overview
Table 51 Thermo Fisher Scientific Inc.: Product Portfolio
Table 52 Thermo Fisher Scientific Inc.: Key Developments
Table 53 Hologic Inc.: Overview
Table 54 Hologic Inc.: Product Portfolio
Table 55 Hologic Inc.: Key Developments
Table 56 PerkinElmer: Overview
Table 57 PerkinElmer: Product Portfolio
Table 58 PerkinElmer: Key Developments
Table 59 Lumos Diagnostics: Overview
Table 60 Lumos Diagnostics: Product Portfolio
Table 61 Lumos Diagnostics: Key Developments
Table 62 BioAssay Works, LLC: Overview
Table 63 BioAssay Works, LLC: Product Portfolio
Table 64 BioAssay Works, LLC: Key Developments
LIST OF FIGURES
Figure 1 Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Lateral Flow Assays Market Share, By Product, 2024 & 2033 (%)
Figure 3 Global Lateral Flow Assays Market Share, By Technique, 2024 & 2033 (%)
Figure 4 Global Lateral Flow Assays Market Share, By Application, 2024 & 2033 (%)
Figure 5 Global Lateral Flow Assays Market Share, By End-User, 2024 & 2033 (%)
Figure 6 Global Lateral Flow Assays Market Share, By Region, 2024 & 2033 (%)
Figure 7 Global Lateral Flow Assays Market Y-o-Y Growth, By Product, 2023-2033 (%)
Figure 8 Kits & Reagents Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 9 Lateral Flow Readers Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 10 Global Lateral Flow Assays Market Y-o-Y Growth, By Technique, 2023-2033 (%)
Figure 11 Sandwich Assays Technique in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 12 Competitive Assays Technique in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 13 Multiplex Detection Assays Technique in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 14 Global Lateral Flow Assays Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 15 Drug Development & Quality Testing Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 16 Food Safety & Environmental Safety, Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 17 Pregnancy & Fertility Testing Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 18 Cardiac Markers Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 19 Infectious Diseases Testing Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 20 Drugs of Abuse Testing Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 21 Clinical Testing Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 22 Cholesterol/Lipid Testing Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 23 Other Clinical Tests Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 24 Global Lateral Flow Assays Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 25 Pharmaceutical and Biotechnology Companies End-User in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 26 Hospitals and Clinics End-User in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 27 Diagnostic Laboratories End-User in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 28 Home Care End-User in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 29 Others End-User in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 30 Global Lateral Flow Assays Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 31 North America Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 32 North America Lateral Flow Assays Market Share, By Product, 2024 & 2033 (%)
Figure 33 North America Lateral Flow Assays Market Share, By Technique, 2024 & 2033 (%)
Figure 34 North America Lateral Flow Assays Market Share, By Application, 2024 & 2033 (%)
Figure 35 North America Lateral Flow Assays Market Share, By End-User, 2024 & 2033 (%)
Figure 36 North America Lateral Flow Assays Market Share, By Country, 2024 & 2033 (%)
Figure 37 Asia-Pacific Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 38 Asia-Pacific Lateral Flow Assays Market Share, By Product, 2024 & 2033 (%)
Figure 39 Asia-Pacific Lateral Flow Assays Market Share, By Technique, 2024 & 2033 (%)
Figure 40 Asia-Pacific Lateral Flow Assays Market Share, By Application, 2024 & 2033 (%)
Figure 41 Asia-Pacific Lateral Flow Assays Market Share, By End-User, 2024 & 2033 (%)
Figure 42 Asia-Pacific Lateral Flow Assays Market Share, By Country, 2024 & 2033 (%)
Figure 43 Europe Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 44 Europe Lateral Flow Assays Market Share, By Product, 2024 & 2033 (%)
Figure 45 Europe Lateral Flow Assays Market Share, By Technique, 2024 & 2033 (%)
Figure 46 Europe Lateral Flow Assays Market Share, By Application, 2024 & 2033 (%)
Figure 47 Europe Lateral Flow Assays Market Share, By End-User, 2024 & 2033 (%)
Figure 48 Europe Lateral Flow Assays Market Share, By Country, 2024 & 2033 (%)
Figure 49 South America Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 50 South America Lateral Flow Assays Market Share, By Product, 2024 & 2033 (%)
Figure 51 South America Lateral Flow Assays Market Share, By Technique, 2024 & 2033 (%)
Figure 52 South America Lateral Flow Assays Market Share, By Application, 2024 & 2033 (%)
Figure 53 South America Lateral Flow Assays Market Share, By End-User, 2024 & 2033 (%)
Figure 54 South America Lateral Flow Assays Market Share, By Country, 2024 & 2033 (%)
Figure 55 Middle East and Africa Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 56 Middle East and Africa Lateral Flow Assays Market Share, By Product, 2024 & 2033 (%)
Figure 57 Middle East and Africa Lateral Flow Assays Market Share, By Technique, 2024 & 2033 (%)
Figure 58 Middle East and Africa Lateral Flow Assays Market Share, By Application, 2024 & 2033 (%)
Figure 59 Middle East and Africa Lateral Flow Assays Market Share, By End-User, 2024 & 2033 (%)
Figure 60 QIAGEN: Financials
Figure 61 Abbott: Financials
Figure 62 Merck KGaA: Financials
Figure 63 Thermo Fisher Scientific Inc.: Financials
Figure 64 Hologic Inc.: Financials
Figure 65 PerkinElmer: Financials
Figure 66 Lumos Diagnostics: Financials
Figure 67 BioAssay Works, LLC: Financials
Figure 1 Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Lateral Flow Assays Market Share, By Product, 2024 & 2033 (%)
Figure 3 Global Lateral Flow Assays Market Share, By Technique, 2024 & 2033 (%)
Figure 4 Global Lateral Flow Assays Market Share, By Application, 2024 & 2033 (%)
Figure 5 Global Lateral Flow Assays Market Share, By End-User, 2024 & 2033 (%)
Figure 6 Global Lateral Flow Assays Market Share, By Region, 2024 & 2033 (%)
Figure 7 Global Lateral Flow Assays Market Y-o-Y Growth, By Product, 2023-2033 (%)
Figure 8 Kits & Reagents Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 9 Lateral Flow Readers Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 10 Global Lateral Flow Assays Market Y-o-Y Growth, By Technique, 2023-2033 (%)
Figure 11 Sandwich Assays Technique in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 12 Competitive Assays Technique in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 13 Multiplex Detection Assays Technique in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 14 Global Lateral Flow Assays Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 15 Drug Development & Quality Testing Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 16 Food Safety & Environmental Safety, Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 17 Pregnancy & Fertility Testing Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 18 Cardiac Markers Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 19 Infectious Diseases Testing Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 20 Drugs of Abuse Testing Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 21 Clinical Testing Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 22 Cholesterol/Lipid Testing Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 23 Other Clinical Tests Application in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 24 Global Lateral Flow Assays Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 25 Pharmaceutical and Biotechnology Companies End-User in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 26 Hospitals and Clinics End-User in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 27 Diagnostic Laboratories End-User in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 28 Home Care End-User in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 29 Others End-User in Global Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 30 Global Lateral Flow Assays Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 31 North America Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 32 North America Lateral Flow Assays Market Share, By Product, 2024 & 2033 (%)
Figure 33 North America Lateral Flow Assays Market Share, By Technique, 2024 & 2033 (%)
Figure 34 North America Lateral Flow Assays Market Share, By Application, 2024 & 2033 (%)
Figure 35 North America Lateral Flow Assays Market Share, By End-User, 2024 & 2033 (%)
Figure 36 North America Lateral Flow Assays Market Share, By Country, 2024 & 2033 (%)
Figure 37 Asia-Pacific Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 38 Asia-Pacific Lateral Flow Assays Market Share, By Product, 2024 & 2033 (%)
Figure 39 Asia-Pacific Lateral Flow Assays Market Share, By Technique, 2024 & 2033 (%)
Figure 40 Asia-Pacific Lateral Flow Assays Market Share, By Application, 2024 & 2033 (%)
Figure 41 Asia-Pacific Lateral Flow Assays Market Share, By End-User, 2024 & 2033 (%)
Figure 42 Asia-Pacific Lateral Flow Assays Market Share, By Country, 2024 & 2033 (%)
Figure 43 Europe Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 44 Europe Lateral Flow Assays Market Share, By Product, 2024 & 2033 (%)
Figure 45 Europe Lateral Flow Assays Market Share, By Technique, 2024 & 2033 (%)
Figure 46 Europe Lateral Flow Assays Market Share, By Application, 2024 & 2033 (%)
Figure 47 Europe Lateral Flow Assays Market Share, By End-User, 2024 & 2033 (%)
Figure 48 Europe Lateral Flow Assays Market Share, By Country, 2024 & 2033 (%)
Figure 49 South America Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 50 South America Lateral Flow Assays Market Share, By Product, 2024 & 2033 (%)
Figure 51 South America Lateral Flow Assays Market Share, By Technique, 2024 & 2033 (%)
Figure 52 South America Lateral Flow Assays Market Share, By Application, 2024 & 2033 (%)
Figure 53 South America Lateral Flow Assays Market Share, By End-User, 2024 & 2033 (%)
Figure 54 South America Lateral Flow Assays Market Share, By Country, 2024 & 2033 (%)
Figure 55 Middle East and Africa Lateral Flow Assays Market Value, 2022-2033 (US$ Billion)
Figure 56 Middle East and Africa Lateral Flow Assays Market Share, By Product, 2024 & 2033 (%)
Figure 57 Middle East and Africa Lateral Flow Assays Market Share, By Technique, 2024 & 2033 (%)
Figure 58 Middle East and Africa Lateral Flow Assays Market Share, By Application, 2024 & 2033 (%)
Figure 59 Middle East and Africa Lateral Flow Assays Market Share, By End-User, 2024 & 2033 (%)
Figure 60 QIAGEN: Financials
Figure 61 Abbott: Financials
Figure 62 Merck KGaA: Financials
Figure 63 Thermo Fisher Scientific Inc.: Financials
Figure 64 Hologic Inc.: Financials
Figure 65 PerkinElmer: Financials
Figure 66 Lumos Diagnostics: Financials
Figure 67 BioAssay Works, LLC: Financials
